← Eichor
Condition: Hepatitis C Virus Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hepatitis C Virus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
NA · 32 location(s) · Kirby Institute · NCT03685045The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
Phase N/A · 1 location(s) · The Task Force for Global Health · NCT05368974Evaluation of Patients With Liver Disease
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00001971Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum
NA · 1 location(s) · Johns Hopkins University · NCT04162938Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Phase N/A · 1 location(s) · Northwestern University · NCT01644903Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT05361603Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · 13 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05832229California MEPS Hub
NA · 3 location(s) · University of California, Los Angeles · NCT07433985Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania
EARLY_Phase 1 · 1 location(s) · Médecins du Monde · NCT06159504Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder
Phase 2/Phase 3 · 1 location(s) · White River Junction Veterans Affairs Medical Center · NCT05637879Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chron
NA · 2 location(s) · University of Guadalajara · NCT07487623Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data
Phase N/A · 2 location(s) · AbbVie · NCT07419347Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Canc
Phase N/A · 4 location(s) · Centro di Riferimento Oncologico - Aviano · NCT06718530Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada
Phase N/A · 12 location(s) · McGill University · NCT07095192Hepatitis C Pharmacist, Physician, Patient Navigator Collaborative Care Model in Permanent Supportive Housing
NA · 1 location(s) · University of Washington · NCT07667101Treatment as Prevention for Hepatitis C in Iceland
Phase N/A · 1 location(s) · Landspitali University Hospital · NCT02647879The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)
Phase 1 · 1 location(s) · Virginia Commonwealth University · NCT06062966"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chron
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04690972Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of D
Phase N/A · 2 location(s) · University of Oxford · NCT06658782Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
NA · 1 location(s) · H. Lee Moffitt Cancer Center and Research Institute · NCT06745895Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipien
Phase 2 · 3 location(s) · Baylor Research Institute · NCT03383419Implementing Low-Barrier HCV Treatment in a Jail Setting
Phase 4 · 1 location(s) · Lifespan · NCT06953479Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria
Phase N/A · 1 location(s) · Vanessa Stadlbauer-Koellner, MD · NCT06834178The National Australian HCV Point-of-Care Testing Program - Minimal Dataset
Phase N/A · 11 location(s) · Kirby Institute · NCT05248555Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants
Phase N/A · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06544863Project I Test: Implementing HIV Testing in Opioid Treatment Programs
NA · 1 location(s) · Columbia University · NCT03135886Blood Collection Biorepository for Liver Disease Research
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT03025074Effect of Some Drugs on Liver Fibrosis
Phase 3 · 1 location(s) · Sherief Abd-Elsalam · NCT03770936Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C Wi
Phase 1/Phase 2 · 10 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07040319Persuasive Health Communication Intervention for HIV/HCV
NA · 1 location(s) · University of South Florida · NCT05968573
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.